Wells Fargo Upgrades NeuroPace to Overweight, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Lawrence Biegelsen upgraded NeuroPace (NASDAQ:NPCE) from Equal-Weight to Overweight and increased the price target from $16 to $20.
March 14, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo upgraded NeuroPace from Equal-Weight to Overweight and raised the price target from $16 to $20.
The upgrade by a major financial institution like Wells Fargo, along with a significant increase in the price target, is likely to instill positive sentiment among investors. This could lead to increased demand for NPCE shares, pushing the price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100